The MGuard PrimeTM Embolic Protection System (EPS), integrated with MicroNetTM (see Our Technology), is designed to trap and seal thrombus and ruptured plaque, prevent distal embolization, and optimize flow, while ensuring excellent deliverabililty.
While offering performance that is superior to standard STEMI therapy, MGuard Prime requires no change in current physician practice – an important factor in time-critical settings.
|Stent Length (mm)|
The MGuard Prime EPS is indicated for improving luminal diameter in vessels with reference diameter from 2.5 to 4.0 mm having lesion length <38 mm and providing embolic protection in patients undergoing primary or rescue PCI for acute ST-segment elevation myocardial infarction (STEMI) or non ST-elevation acute coronary syndromes (unstable angina and non ST-segment elevation myocardial infarction). It is also indicated for providing embolic protection in cases of symptomatic coronary artery disease (CAD) due to a discrete de novo or restenotic lesion in a native coronary artery or a culprit lesion in a saphenous vein graft. MGuard Prime also treat coronary lesion having atherothrombotic appearance in patients with non ST-elevation acute coronary syndromes (unstable angina and non ST-segment elevation myocardial infarction).
MGuard PrimeTM EPS is CE Mark approved. It is not approved for sale in the U.S.A.